Business Standard

Pharma regulator NPPA warns industry of stricter price action

Within the sector, there has been a buzz that the draft policy has been put in the cold storage because of opposition from industry

Pharma
Premium

Pharma

Aneesh Phadnis Mumbai
The National Pharmaceutical Pricing Authority (NPPA) has warned the pharmaceutical industry of stricter price regulation, a move which could weaken sales growth of the sector.

“The pricing regime will be strict than what it is so far. The government is answerable to the people,” NPPA Chairman Bhupendra Singh said at an Indian Drug Manufacturers Association event in Mumbai on Saturday. He did not specify the proposed actions.

The move comes in the backdrop of government scrutiny of industry practices which found excessive trade margins and exorbitant drug prices among others.

Singh said trade margins for 25 per cent of drugs sold in the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in